Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-16 | 2024-06 | -9.91 | -19.28 | -9.37 | -94.55% |
2024-05-13 | 2024-03 | -16.61 | -5.75 | 10.86 | 65.38% |
2024-04-01 | 2023-12 | -49.84 | -27.48 | 22.36 | 44.86% |
2023-11-09 | 2023-09 | -47.6 | -58.47 | -10.87 | -22.84% |
2023-08-10 | 2023-06 | -88.82 | -85.62 | 3.2 | 3.60% |
2023-05-08 | 2023-03 | -79.87 | -103.83 | -23.96 | -30.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-07-31 | Alliance Global Partners | Upgrade | Buy | Buy |
2023-06-01 | Alliance Global Partners | Upgrade | Buy | Buy |
2021-08-30 | Alliance Global Partners | Upgrade | Buy | Buy |
2021-08-10 | Alliance Global Partners | Upgrade | Buy | Buy |
2021-02-24 | Alliance Global Partners | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2020-08-12 | BAGGER RICHARD H | Director | 10.00K | Purchase |
2020-08-19 | BELL MARGARET SMITH | Director | 5.39K | Purchase |
2021-05-24 | GOODMAN DANIEL WINTNER M.D. | Director | 5.00K | Purchase |
2022-06-28 | LEDERMAN SETH | Chief Executive Officer | 0.00 | Purchase |
2018-06-24 | MARIO ERNEST B | Director | 0.00 | Purchase |
2018-06-13 | MORRIS JESSICA EDGAR | Chief Operating Officer | 1.64K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 398.75K | 630.03K | 2.24% |
2023-06-29 | Renaissance Technologies, LLC | 211.42K | 334.05K | 1.19% |
2023-06-29 | Geode Capital Management, LLC | 85.37K | 134.88K | 0.48% |
2023-06-29 | Acadian Asset Management. LLC | 68.74K | 108.61K | 0.39% |
2023-06-29 | Blackrock Inc. | 48.34K | 76.38K | 0.27% |
2023-06-29 | Raymond James & Associates, Inc. | 44.36K | 70.10K | 0.25% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 297.30K | 469.74K | 1.67% |
2023-06-29 | Vanguard Extended Market Index Fund | 100.84K | 159.33K | 0.57% |
2023-05-30 | Fidelity Extended Market Index Fund | 49.98K | 89.47K | 0.28% |
2023-05-30 | Fidelity Total Market Index Fund | 13.51K | 24.18K | 0.08% |
2023-05-30 | Fidelity Series Total Market Index Fund | 9.14K | 16.35K | 0.05% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 6.31K | 6.10K | 0.04% |
Split | Date |
---|---|
1 : 32 | 2024-06-10 |
4 : 25 | 2023-05-10 |
1 : 32 | 2022-05-17 |
1 : 10 | 2019-11-01 |
1 : 10 | 2018-11-28 |
1 : 10 | 2017-03-17 |
-
@dell close your position you idiot hater
-
Feeling bullish 50 crosses 200 on the daily and this month and 4th QT this stock has great potential!
-
-
The TNX-102 phase 3 fibromyalgia data will be released this month and the shorts will burn
-
-
In at 1.04 average much greater upside potential
-
Catalyst $FRSX an innovator in automotive vision systems, announced today that Eli Yoresh, Chief Financial Officer, and Doron Cohadier, Vice President of Business Development, will present virtually at the LD Micro 500 Virtual Conference on Tuesday, September 1st, 2020 at 12:00 p.m. EDT
-
$1 today
-
Much more upside potential than downside holding strong
-
Average @ 1.02 still holding
-
-
This isn’t going to the .60s that’s what some of you wish!!
-
-
Will rebound almost everything in this sector is down
-
Any advice on $TNXP for a poor retired veteran in at $2.10?
Discord Cream3.14#6753 -
17k shares its all good better days to come bulls
-
-
-
Taking the lead: Tonix Pharmaceuticals Holding Corp (TNXP)
news.google.com • -
Examining Tonix Pharmaceuticals Holding Corp (TNXP) stock is warranted
news.google.com • -
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
globenewswire.com • -
Tonix Pharmaceuticals Announces Proposed Public Offering
globenewswire.com • -
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
globenewswire.com • -
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?
investorplace.com •